About US
Contact us
-
Hospital-treated infections market to exceed $4bn by 2020The market for drugs used for hospital-treated infections such as MRSA will increase to over $4bn by 2020, according to forecasts produced by Decision Resources. Although there is increased competi2011/11/30
-
Novartis submits NVA237 for Japanese approvalNovartis has submitted NVA237, the company's new treatment for chronic obstructive pulmonary disease, for approval in Japan. The drug, which was submitted for European approval in September 2011 unde2011/11/29
-
Merck to send water test kits to flood-hit ThailandMerck has sent thousands of water test kits to flood-hit Thailand in an effort to safeguard the quality of drinking water and prevent the spread of waterborne diseases. The company's Merck Millipore2011/11/29
-
Pfizer to buy Excaliard PharmaceuticalsPfizer has entered into a definitive agreement to acquire Excaliard Pharmaceuticals, gaining access to EXC 001, a skin scarring treatment. Co-developed by Excaliard and Isis Pharmaceuticals, EXC 0012011/11/28
-
SFDA issues Guiding Opinions on Enhancing the Construction of Adverse Drug Reaction Monitoring SystemTo implement the relevant requirements of the reform of the medical and health care system, further improve the adverse drug reaction reporting and monitoring system, improve the capability of monitor2011/11/25
-
The 2nd International Forum on Rapid Drug Testing & 3rd China-US Joint Symposium on Pharmaceutical Analytical Technology & Compendial Methods held in HangzhouOn November 15-16, 2011, the 2nd International Forum on Rapid Drug Testing & 3rd China-US Joint Symposium on Pharmaceutical Analytical Technology & Compendial Methods, jointly organized by the2011/11/25
-
Study reveals principal mechanism of action for paracetamolResearchers at King's College London have discovered how one of the most common household painkillers works, which could pave the way for less harmful pain relief medications to be developed in the fu2011/11/24
-
Merck settles Vioxx lawsuit in the USMerck has agreed to pay a $950m fine to settle criminal and civil charges that it misrepresented the safety of its anti-inflammatory drug Vioxx. Under civil settlement agreements signed with the US a2011/11/24
-
Indian supreme court slams drug pricesThe Supreme Court of India has informed the country's central government that drug prices are too high and should not be raised again. The criticism came during a Public Interest Litigation hearing,2011/11/24
-
Merck agrees to pay $950 million in Vioxx safety probeBy Dr Ananya Mandal, MD Merck & Co. will pay $950 million and one of its units will plead guilty to a criminal charge to resolve a U.S. probe of its illegal marketing of the painkiller Vioxx.2011/11/23